VCEL - ヴェリセル (Vericel Corporation)

VCELのニュース

   The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica  2020/12/29 13:09:37 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Allakos Inc (NASDAQ: ALLK ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arvinas Inc (NASDAQ: ARVN ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) BIO-TECHNE Corp (NASDAQ: TECH ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Cellectis SA (NASDAQ: CLLS ) Crispr Therapeutics AG (NASDAQ: CRSP ) Curis, Inc. (NASDAQ: CRIS ) Edwards Lifesciences Corp (NYSE: EW ) ESSA Pharma Inc (NASDAQ: EPIX ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) Inari Medical Inc (NASDAQ: NARI ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Kodiak Sciences Inc (NASDAQ: KOD ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Lumos Pharma Inc (NASDAQ: LUMO ) Medicenna Therapeutics Corp (NASDAQ: MDNA ) Myovant Sciences Ltd (NYSE: MYOV ) - announced a licensing deal with Pfizer Inc.
   Vericel to Present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021  2020/12/18 13:30:00 GlobeNewswire
CAMBRIDGE, Mass., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe…
   The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod  2020/12/02 12:35:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 1) AbbVie Inc (NYSE: ABBV ) Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT ) argenx SE – ADR (NASDAQ: ARGX ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Auris Medical Holding Ltd (NASDAQ: EARS ) (announced positive efficacy data from lab testing of AM-301 against airborne pathogens and allergens, including SARS-CoV-2) Beam Therapeutics Inc (NASDAQ: BEAM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BioNTech SE – ADR (NASDAQ: BNTX ) BioTelemetry Inc (NASDAQ: BEAT ) Blueprint Medicines Corp (NASDAQ: BPMC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) (announced FDA acceptance of NDA for infigratinib for individuals with cancer of the bile ducts) Cardiff Oncology Inc (NASDAQ: CRDF ) Cellectis SA (NASDAQ: CLLS ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Codiak BioSciences Inc (NASDAQ: CDAK ) strong>Crispr Therapeutics AG (NASDAQ: CRSP ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Foghorn Therapeutics Inc.
   Cell Therapy Market With Leading Players like Kolon TissueGene, MEDIPOST, JCR Pharmaceuticals Co. Ltd. Stemedica Cell Technologies, Osiris Therapeutics, NuVasive, Fibrocell Science, Vericel Corporation, Cells for Cells, Celgene Corporation  2020/11/18 04:06:59 OpenPR
Cell therapy (CT) is the process of transplanting human cells to replace or repair damaged tissue or cells. Various methods can be used to carry out cell therapy. For instance, hematopoietic stem cell transplantation, also known as bone marrow transplant,
   The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration  2020/11/17 13:31:52 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16) Aligos Therapeutics Inc (NASDAQ: ALGS ) (announced multiple presentations at the Liver Meeting) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Champions Oncology Inc (NASDAQ: CSBR ) CureVac BV (NASDAQ: CVAC )(announced a vaccine supply deal with the European Commission) Eidos Therapeutics Inc (NASDAQ: EIDX ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kazia Therapeutics Ltd (NASDAQ: KZIA ) Keros Therapeutics Inc (NASDAQ: KROS ) Moderna Inc (NASDAQ: MRNA ) ( announced positive interim efficacy data for the Phase 3 study of its coronavirus vaccine candidate) Myokardia Inc (NASDAQ: MYOK ) Neuronetics Inc (NASDAQ: STIM ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Oncorus Inc (NASDAQ: ONCR ) Pacira Biosciences Inc (NASDAQ: PCRX ) Shockwave Medical Inc (NASDAQ: SWAV ) Spruce Biosciences Inc (NASDAQ: SPRB ) Summit Therapeutics Inc (NASDAQ: SMMT ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Tcr2 Therapeutics Inc (NASDAQ: TCRR ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) (announced regulatory filing for envafolimab in the indication of MSI-H/dMMR cancer, in China) Trinity Biotech plc (NASDAQ: TRIB ) United Therapeutics Corporation (NASDAQ: UTHR ) Veracyte Inc (NASDAQ: VCYT ) Vericel Corp (NASDAQ: VCEL ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov.
   The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod  2020/12/02 12:35:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 1) AbbVie Inc (NYSE: ABBV ) Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT ) argenx SE – ADR (NASDAQ: ARGX ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Auris Medical Holding Ltd (NASDAQ: EARS ) (announced positive efficacy data from lab testing of AM-301 against airborne pathogens and allergens, including SARS-CoV-2) Beam Therapeutics Inc (NASDAQ: BEAM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BioNTech SE – ADR (NASDAQ: BNTX ) BioTelemetry Inc (NASDAQ: BEAT ) Blueprint Medicines Corp (NASDAQ: BPMC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) (announced FDA acceptance of NDA for infigratinib for individuals with cancer of the bile ducts) Cardiff Oncology Inc (NASDAQ: CRDF ) Cellectis SA (NASDAQ: CLLS ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Codiak BioSciences Inc (NASDAQ: CDAK ) strong>Crispr Therapeutics AG (NASDAQ: CRSP ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Foghorn Therapeutics Inc.
   Cell Therapy Market With Leading Players like Kolon TissueGene, MEDIPOST, JCR Pharmaceuticals Co. Ltd. Stemedica Cell Technologies, Osiris Therapeutics, NuVasive, Fibrocell Science, Vericel Corporation, Cells for Cells, Celgene Corporation  2020/11/18 04:06:59 OpenPR
Cell therapy (CT) is the process of transplanting human cells to replace or repair damaged tissue or cells. Various methods can be used to carry out cell therapy. For instance, hematopoietic stem cell transplantation, also known as bone marrow transplant,
   The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration  2020/11/17 13:31:52 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16) Aligos Therapeutics Inc (NASDAQ: ALGS ) (announced multiple presentations at the Liver Meeting) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Champions Oncology Inc (NASDAQ: CSBR ) CureVac BV (NASDAQ: CVAC )(announced a vaccine supply deal with the European Commission) Eidos Therapeutics Inc (NASDAQ: EIDX ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kazia Therapeutics Ltd (NASDAQ: KZIA ) Keros Therapeutics Inc (NASDAQ: KROS ) Moderna Inc (NASDAQ: MRNA ) ( announced positive interim efficacy data for the Phase 3 study of its coronavirus vaccine candidate) Myokardia Inc (NASDAQ: MYOK ) Neuronetics Inc (NASDAQ: STIM ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Oncorus Inc (NASDAQ: ONCR ) Pacira Biosciences Inc (NASDAQ: PCRX ) Shockwave Medical Inc (NASDAQ: SWAV ) Spruce Biosciences Inc (NASDAQ: SPRB ) Summit Therapeutics Inc (NASDAQ: SMMT ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Tcr2 Therapeutics Inc (NASDAQ: TCRR ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) (announced regulatory filing for envafolimab in the indication of MSI-H/dMMR cancer, in China) Trinity Biotech plc (NASDAQ: TRIB ) United Therapeutics Corporation (NASDAQ: UTHR ) Veracyte Inc (NASDAQ: VCYT ) Vericel Corp (NASDAQ: VCEL ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov.
   H.C. Wainwright Stick to Their Buy Rating for Vericel Corp  2020/11/09 11:19:08 Investing.com
H.C. Wainwright Stick to Their Buy Rating for Vericel Corp
   Vericel Reports Record Third Quarter Revenues and Net Income  2020/11/05 13:00:00 GlobeNewswire
Total Net Revenues of $32.3 Million and Net Income of $3.6 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE…
   H.C. Wainwright Stick to Their Buy Rating for Vericel Corp  2020/11/09 11:19:08 Investing.com
H.C. Wainwright Stick to Their Buy Rating for Vericel Corp
   Vericel Reports Record Third Quarter Revenues and Net Income  2020/11/05 13:00:00 GlobeNewswire
Total Net Revenues of $32.3 Million and Net Income of $3.6 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE…
   Sitting on a Cash Pile 7.0? Sports Biopharma - Live Trading News  2020/11/03 16:04:40 Live Trading News
#cash #cell #buy #burn #sports #biopharma $VCEL Vericel Corp. (NASDAQ:VCEL) broke out on 4 September at 16.90, it has yet to confirm, so this an early Buy call, as a Key technical indicator just turned Bullish. The Key support is at 15.19 and the Key overhead resistance is at 19.62, a strong close over that […]
   Vericel to Present at Upcoming Investor Conferences  2020/11/02 13:30:00 GlobeNewswire
CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe…
   Outstanding Scope of Regenerative Medicines Market is Estimated to Grow Incredible CAGR +23% till 2027 | Top most Key Players like Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation  2020/10/26 13:15:01 OpenPR
Regenerative medicine is the piece of medicine that makes procedures to regrow, fix or supersede hurt or undesirable cells, organs or tissues. Regenerative medicine joins the age and use of remedial fundamental microorganisms, tissue building and the making of phony

calendar